The loss of phenol sulfotransferase 1 in hepatocellular carcinogenesis
Authors:
- 21 January 2010
- journal article
- research article
- Published by Wiley in Proteomics
- Vol. 10 (2) , 266-276
Abstract
Biomarkers for the detection of early hepatocellular carcinoma (HCC) are urgently needed. To identify biomarkers of HCC, we performed a comparative proteomics analysis, based on 2‐DE of HCC tissues and surrounding non‐tumor tissues. Six xenobiotic enzymes were significantly down‐regulated in the HCC tissue. Among these, phenol sulfotransferase (SULT1A1) was confirmed by Western blot analysis in 105 HCC patients. SULT1A1 showed a significant decrease in 98.1% of the HCC tissues, with 88.6% sensitivity and 66.7% specificity for the detection of HCC. Immunohistochemistry for SULT1A1 was performed and compared with glypican‐3, which is a well‐known marker of HCC. The results showed down‐regulation of SULT1A1 and up‐regulation of glypican‐3 in 52.6 and 71.9% of the HCCs, and the use of both markers improved the sensitivity up to 78.9%. Moreover, SULT1A1 was useful in differentiating early HCC from benign dysplastic nodules. Clinically, the down‐regulation of SULT1A1 was closely associated with an advanced International Union Against Cancer stage and high levels of serum α‐fetoprotein. In conclusion, the results of this study demonstrate that the loss of SULT1A1 appears to be a characteristic molecular signature of HCC. SULT1A1 might be a useful biomarker for the detection of early HCC and help predict the clinical outcome of patients with HCC.Keywords
Funding Information
- Korea Health 21 R&D Project (Ministry of Health, Welfare and Family Affairs, Republic of Korea (A010383, A030003)
This publication has 24 references indexed in Scilit:
- Proteome Analysis of Hepatocellular Carcinoma by Two-dimensional Difference Gel ElectrophoresisMolecular & Cellular Proteomics, 2007
- Toward the discovery of new biomarkers of hepatocellular carcinoma by proteomicsLiver International, 2007
- Proteomic analysis of cancer tissues: Shedding light on carcinogenesis and possible biomarkersProteomics, 2006
- Management of Hepatocellular Carcinoma *Hepatology, 2005
- Characterization of Small Nodules in Cirrhosis by Assessment of Vascularity: The Problem of Hypovascular Hepatocellular Carcinoma *Hepatology, 2005
- Overexpression of alpha enolase in hepatitis C virus‐related hepatocellular carcinoma: Association with tumor progression as determined by proteomic analysisProteomics, 2005
- Primary liver cancer: Worldwide incidence and trendsGastroenterology, 2004
- Accurate Qualitative and Quantitative Proteomic Analysis of Clinical Hepatocellular Carcinoma Using Laser Capture Microdissection Coupled with Isotope-coded Affinity Tag and Two-dimensional Liquid Chromatography Mass SpectrometryMolecular & Cellular Proteomics, 2004
- Detection and identification of tumor-associated protein variants in human hepatocellular carcinomasHepatology, 2004
- Hepatocellular carcinomaThe Lancet, 2003